Skip to content
(480) 999-0905
FacebookLinkedin
Arizona's Only Accredited Master Surgeon - Greg J. Marchand M.D.Arizona's Only Accredited Master Surgeon - Greg J. Marchand M.D.
Arizona's Only Accredited Master Surgeon – Greg J. Marchand M.D.
Arizona's Only Accredited Master Surgeon – Greg J. Marchand M.D.
  • Dr. Greg Marchand
  • Fellowship Program
  • Publications
  • Media
  • Travel to AZ for Surgery
  • Contact us
  • Dr. Greg Marchand
  • Fellowship Program
  • Publications
  • Media
  • Travel to AZ for Surgery
  • Contact us

Fresh Off the Press in AJOG MFM: Marchand Institute’s New Meta-Analysis on Single- vs. Double-Layer Uterine Closure and Cesarean Scar Outcomes

July 28, 2026OBGYNBy Maria Sainz

The Marchand Institute for Minimally Invasive Surgery is pleased to announce the online publication of our latest research, appearing today in the American Journal of Obstetrics & Gynecology MFM (AJOG MFM). Our new paper, titled “Single- versus Double-Layer Uterine Closure and Cesarean Scar Outcomes at Defined Postpartum Intervals: A Time-Stratified Meta-Analysis of Randomized Trials,” takes a fresh, time-based look at one of the most debated questions in cesarean technique.

With cesarean delivery among the most common surgical procedures performed worldwide, the way the uterus is closed has real, long-term implications for cesarean scar healing and future pregnancies. This study was designed to clarify how single-layer and double-layer closure compare when outcomes are measured at consistent points in time after delivery.

Read the Full Study Here:

PubMed (NCBI): PMID: 42508570

Official Journal Link (Elsevier): DOI: 10.1016/j.ajogmf.2026.102073

Why Uterine Closure Technique Matters

After a cesarean delivery, the uterine incision can heal in ways that leave behind a “niche” — a defect in the scar that has been linked to abnormal bleeding, pain, and complications in subsequent pregnancies. Two techniques dominate practice: closing the uterine wall in a single layer or in two layers. Prior studies have offered conflicting conclusions, in part because they measured healing at different, inconsistent times after surgery.

Study Design and Methodology

Our team conducted a systematic review and time-stratified meta-analysis of randomized controlled trials, following PRISMA guidelines. We searched PubMed, Cochrane CENTRAL, Scopus, and Web of Science from inception through November 10, 2025. Two reviewers independently screened records, extracted data, and assessed risk of bias using Cochrane RoB 2, with results pooled using random-effects models and stratified by follow-up interval (6 weeks, 3 months, 6 months, and 12 months) so that each technique was compared at the same point in time.

In total, 21 randomized controlled trials representing 8,564 women met our eligibility criteria after a trustworthiness assessment.

Key Findings

  • Uterine rupture or dehiscence: The primary outcome did not differ significantly between the two techniques (risk ratio 1.97, 95% CI 0.66–5.94).
  • Niche incidence: No significant difference was found between single- and double-layer closure at any time point.
  • Residual myometrial thickness: Double-layer closure was associated with a thicker residual myometrium at 6 weeks (mean difference -1.07 mm) and at 6 months (mean difference -1.16 mm).
  • Niche depth: Single-layer closure was associated with a shallower niche depth at 3 months (mean difference -1.29 mm).

Clinical Takeaways

The findings suggest that while double-layer uterine closure yields greater residual myometrial thickness, it does not appear to reduce niche incidence or the risk of uterine dehiscence compared with single-layer closure. In other words, the improved sonographic markers seen with double-layer closure did not translate into a clear difference in the outcomes that matter most for future pregnancies.

“By aligning our comparisons to the same follow-up intervals, we were able to separate genuine differences in healing from differences that were simply an artifact of when measurements were taken,” notes the research team at the Marchand Institute. “The clinical significance of these sonographic markers remains uncertain, which is exactly why future trials should focus on long-term clinical outcomes.”

Acknowledgements

We would like to thank our dedicated research staff and contributing authors for their work on this project. This collaborative effort is essential for advancing the field of minimally invasive gynecologic surgery (MIGS) and improving care for women worldwide.

About the Marchand Institute

The Marchand Institute for Minimally Invasive Surgery is a non-profit research and educational institution dedicated to the advancement of gynecologic surgery. We focus on developing and evaluating surgical techniques that reduce recovery time, minimize pain, and improve the overall quality of care for women worldwide.

For more information on our surgical fellowships or to view our library of research, please visit MarchandInstitute.org.

Share this:

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook

Like this:

Like Loading…

Related

Cesarean Sectionmeta analysismeta-analysisobgynSystematic Review
Related posts
New Research from Dr. Greg Marchand: Evaluating the Impact of Robotic Assistance in Single-Site Hysterectomy
February 20, 2026
Exciting News: Dr. Marchand’s Latest Meta-Analysis on Opportunistic Salpingectomy for Epithelial Ovarian Cancer Prevention is Published and Open Access!
February 5, 2026
New Systematic Review and Meta-Analysis: Comparative Risk of Neonatal Ischemic Encephalopathy in Operative Vaginal Delivery vs. Cesarean at Complete Dilation – Now Online in AJP!
January 29, 2026
We're thrilled to announce the publication of a groundbreaking systematic review and meta-analysis led by Dr. Greg Marchand and the dedicated research team at the Marchand Institute for Minimally Invasive Surgery! Titled "Laparoendoscopic Single-Site Surgery Versus Conventional Laparoscopic Surgery in Ovarian Cystectomy: A Meta-Analysis", this comprehensive study compares two advanced minimally invasive techniques for removing benign ovarian cysts — Laparoendoscopic Single-Site Surgery (LESS) (using a single small incision, often hidden at the umbilicus for superior cosmetic results) and Conventional Laparoscopic Surgery (CLS) (using multiple small incisions). Analyzing data from 9 studies involving 1,368 women, the meta-analysis reveals compelling insights: LESS is associated with longer operative times (by about 9.4 minutes on average), likely due to the technical demands of working through a single port. However, patients undergoing LESS benefit from a shorter hospital stay (reduced by approximately 0.26 days). Importantly, there are no significant differences in key safety outcomes: postoperative pain scores (at 6 and 24 hours), estimated blood loss, need for opioid analgesics, drop in hemoglobin levels, or overall complication rates. These findings strengthen the evidence that LESS is a safe, effective, and viable alternative to conventional laparoscopy for women with benign ovarian cysts — offering faster recovery and excellent cosmetic advantages while maintaining comparable safety and pain profiles. This work adds valuable high-level evidence to the field of minimally invasive gynecologic surgery and reflects the Marchand Institute's ongoing commitment to advancing women's health through rigorous, volunteer-driven research. Read the full open-access paper for free today: PubMed Central (PMC) (recommended - full text & PDF): https://pmc.ncbi.nlm.nih.gov/articles/PMC12734174/ Direct PDF download: https://pmc.ncbi.nlm.nih.gov/articles/PMC12734174/pdf/jcm-14-08739.pdf Published in Journal of Clinical Medicine (December 10, 2025) – DOI: 10.3390/jcm14248739 We invite clinicians, researchers, and patients interested in the latest advancements in minimally invasive surgery to explore this important contribution. A huge thank you to our incredible team of researchers, students, and collaborators who made this possible — all volunteer efforts dedicated to improving outcomes for women everywhere! Visit us at marchandinstitute.org to learn more about our ongoing research, educational programs, and mission to push the boundaries of minimally invasive techniques.
Newest Paper on Laparoscopic Single Site Ovarian Cystectomy Online Now!
January 1, 2026
New Systematic Review Reveals Gynecologic Surgeons Achieve Superior Outcomes in Pediatric Adnexal Mass Surgery – Now Freely Available Online!
December 18, 2025
Dr. Marchand’s Analysis of Self Collected Pap Smears online today in AJOG!
November 18, 2025
Articles
  • American Journal of Obstetrics & Gynecology MFM (AJOG MFM) journal cover
    Fresh Off the Press in AJOG MFM: Marchand Institute’s New Meta-Analysis on Single- vs. Double-Layer Uterine Closure and Cesarean Scar Outcomes
    July 28, 2026
  • New Research from Dr. Greg Marchand: Evaluating the Impact of Robotic Assistance in Single-Site Hysterectomy
    February 20, 2026
  • Exciting News: Dr. Marchand’s Latest Meta-Analysis on Opportunistic Salpingectomy for Epithelial Ovarian Cancer Prevention is Published and Open Access!
    February 5, 2026
  • New Systematic Review and Meta-Analysis: Comparative Risk of Neonatal Ischemic Encephalopathy in Operative Vaginal Delivery vs. Cesarean at Complete Dilation – Now Online in AJP!
    January 29, 2026
  • We're thrilled to announce the publication of a groundbreaking systematic review and meta-analysis led by Dr. Greg Marchand and the dedicated research team at the Marchand Institute for Minimally Invasive Surgery! Titled "Laparoendoscopic Single-Site Surgery Versus Conventional Laparoscopic Surgery in Ovarian Cystectomy: A Meta-Analysis", this comprehensive study compares two advanced minimally invasive techniques for removing benign ovarian cysts — Laparoendoscopic Single-Site Surgery (LESS) (using a single small incision, often hidden at the umbilicus for superior cosmetic results) and Conventional Laparoscopic Surgery (CLS) (using multiple small incisions). Analyzing data from 9 studies involving 1,368 women, the meta-analysis reveals compelling insights: LESS is associated with longer operative times (by about 9.4 minutes on average), likely due to the technical demands of working through a single port. However, patients undergoing LESS benefit from a shorter hospital stay (reduced by approximately 0.26 days). Importantly, there are no significant differences in key safety outcomes: postoperative pain scores (at 6 and 24 hours), estimated blood loss, need for opioid analgesics, drop in hemoglobin levels, or overall complication rates. These findings strengthen the evidence that LESS is a safe, effective, and viable alternative to conventional laparoscopy for women with benign ovarian cysts — offering faster recovery and excellent cosmetic advantages while maintaining comparable safety and pain profiles. This work adds valuable high-level evidence to the field of minimally invasive gynecologic surgery and reflects the Marchand Institute's ongoing commitment to advancing women's health through rigorous, volunteer-driven research. Read the full open-access paper for free today: PubMed Central (PMC) (recommended - full text & PDF): https://pmc.ncbi.nlm.nih.gov/articles/PMC12734174/ Direct PDF download: https://pmc.ncbi.nlm.nih.gov/articles/PMC12734174/pdf/jcm-14-08739.pdf Published in Journal of Clinical Medicine (December 10, 2025) – DOI: 10.3390/jcm14248739 We invite clinicians, researchers, and patients interested in the latest advancements in minimally invasive surgery to explore this important contribution. A huge thank you to our incredible team of researchers, students, and collaborators who made this possible — all volunteer efforts dedicated to improving outcomes for women everywhere! Visit us at marchandinstitute.org to learn more about our ongoing research, educational programs, and mission to push the boundaries of minimally invasive techniques.
    Newest Paper on Laparoscopic Single Site Ovarian Cystectomy Online Now!
    January 1, 2026
  • New Systematic Review Reveals Gynecologic Surgeons Achieve Superior Outcomes in Pediatric Adnexal Mass Surgery – Now Freely Available Online!
    December 18, 2025
What patients say
  • 14517468_1646198135690553_6990924301147850409_n“I delivered both my beautiful babies with Dr. Marchand and I wouldn’t have it any other way! Every doctor visit up until I was in labor was great, he took all the time to answer all my questions. I didn’t feel rushed in and rushed out of the office. The office was always very clean! The staff were always very friendly. When I was in labor he made sure my birth plan was the most important thing! He always had my best interest in hand! My first delivery I was induced and it took 3 long days and Marchand kept checking on me all hours of the night!! If I did it all over again I’d definitely use Marchand as my OB again!”

    Related

    Alex S.
  • “We congratulate Dr. Greg J. Marchand as SRC’s first Surgeon of Excellence in Minimally Invasive Surgery (SOEMIS) in the United States. To achieve SOEMIS accreditation, Dr. Marchand invited SRC to complete a rigorous onsite inspection and thorough chart review to illustrate his compliance with the program. Dr. Marchand and his practice exemplify SRC’s commitment to patient safety and care.”

    Related

    Ashley DuBray, Senior Director of the Surgical Review Corporation
  • “I initially met Dr. Marchand upon an emergency room visit due to complications during my first pregnancy. My husband and I had recently moved from out of state. Not knowing many people here, in a scary situation and finding myself hospitalized was made a lot easier once we met Dr. Marchand who we decided would be the best doctor to see my care through the pregnancy and ultimate c-section. He always had time for our questions even when we knew he had many other patients. He did a great job with the surgery and follow up care and was very pleasant, patient and professional throughout the process. When we decided to have another baby, he saw us through another pregnancy and c-section and continues to be my OB of choice. I would recommend him in a heartbeat to any girlfriends I know.”

    Related

    Megan E. of Gilbert, AZ
  • “Growing up I have had my fair share of woman health issue from Endometriosis, PCOS, Severe Pelvic Pain, Loss of Pregnancy and Infertility and more pelvic surgeries than I can count. I have seen many different doctors till about 6-7 years ago when I needed emergency surgery and met Dr. Marchand and now I refuse to go to any one else. With the many issues I have had both Dr. Marchand as well as his whole office staff have been so helpful I couldn’t be more grateful. It’s very hard to find an honest, trustworthy doctor these days but rest assured you can’t go wrong with Dr. Greg Marchand. They are open late and almost always can fit you into the schedule for emergencies and you can always reach him no matter what time it is if you have questions. Dr. Marchand is an amazing surgeon and loves what he does. He has delivered many friends and family’s children and hope that one day he will be able to deliver mine as well.”

    Related

    Tomi M. of Gilbert
Arizona's Only Accredited Master Surgeon - Greg J. Marchand M.D.
© Greg Marchand MD

Loading Comments...

    %d